All data are based on the daily closing price as of October 28, 2025
g
Genomictree
228760.KQ
14.20 USD
0.17
+1.21%
Overview
Last close
14.20 usd
Market cap
341.02M usd
52 week high
17.64 usd
52 week low
8.54 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
134.9644
Price/Book Value
4.2587
Enterprise Value
288.46M usd
EV/Revenue
116.5407
EV/EBITDA
24.3324
Key financials
Revenue TTM
2.48M usd
Gross Profit TTM
349679.75 usd
EBITDA TTM
-8.11M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
91.27M usd
Net debt
N/A usd
About
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.